Verona Boosts Funds And Becomes Potential Takeover Target
Excitement Builds For COPD Drug Ensifentrine
The UK biotech is in a strong spot after extending its cash runway to prepare for the launch of ensifentrine, which analysts believe could become a pipeline-in-a-molecule for respiratory diseases.
